ketanserin has been researched along with Hepatitis B Virus Infection in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Excerpt | Relevance | Reference |
---|---|---|
"We measured the hemodynamic effects of intravenous vasopressin, ketanserin (a 5-hydroxytryptamine-2 receptor blocker), and vasopressin plus ketanserin in 33 patients with hepatitis B-related cirrhosis." | 9.07 | Hemodynamic effects of a combination of vasopressin and ketanserin in patients with hepatitis b-related cirrhosis. ( Hsia, HC; Lai, KH; Lee, FY; Lee, SD; Lin, HC; Lin, WJ; Lo, KJ; Tsai, YT; Wang, SS, 1992) |
"We measured the hemodynamic effects of intravenous vasopressin, ketanserin (a 5-hydroxytryptamine-2 receptor blocker), and vasopressin plus ketanserin in 33 patients with hepatitis B-related cirrhosis." | 5.07 | Hemodynamic effects of a combination of vasopressin and ketanserin in patients with hepatitis b-related cirrhosis. ( Hsia, HC; Lai, KH; Lee, FY; Lee, SD; Lin, HC; Lin, WJ; Lo, KJ; Tsai, YT; Wang, SS, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, FY | 1 |
Tsai, YT | 1 |
Lin, HC | 1 |
Lee, SD | 1 |
Hsia, HC | 1 |
Lin, WJ | 1 |
Wang, SS | 1 |
Lai, KH | 1 |
Lo, KJ | 1 |
1 trial available for ketanserin and Hepatitis B Virus Infection
Article | Year |
---|---|
Hemodynamic effects of a combination of vasopressin and ketanserin in patients with hepatitis b-related cirrhosis.
Topics: Aged; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Female; Heart Rate; Hemodynamics; H | 1992 |